Novel Antiviral Agents for Respiratory Viral Infection in Immunocompromised Adults

Respiratory viruses cause significant morbidity and mortality in immunocompromised populations such as stem cell transplant and solid organ transplant patients. Few viruses causing respiratory tract infection have an approved therapy, and many of the viruses have no therapeutic options at all. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawkinson, Dana, Hinthorn, Daniel, Danziger-Isakov, Lara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Transplant and Oncology (M Ison and N Theodoropoulos, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089160/
https://www.ncbi.nlm.nih.gov/pubmed/24146257
http://dx.doi.org/10.1007/s11908-013-0370-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089160/
https://www.ncbi.nlm.nih.gov/pubmed/24146257
http://dx.doi.org/10.1007/s11908-013-0370-0

Ejemplares similares